VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BOW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BOWBowhead Specialty Holdings Inc.
$30.01$985M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBOWQuarterly Financials

Bowhead Specialty Holdings Inc. (BOW) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bowhead Specialty Holdings Inc. (BOW) quarterly income statement — complete revenue, gross profit & net income history

BOW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'23
Revenue154.81M151.69M143.9M133.18M122.76M119.33M116.72M98.9M90.64M82.85M59.07M
Revenue Growth %26.11%27.12%23.28%34.66%35.44%44.04%--53.43%--
Medical Costs & Claims91.48M104.25M97.12M89.94M83.22M76.07M76.99M66.6M60.84M58.41M38.03M
Medical Cost Ratio %59.09%68.73%67.49%67.53%67.79%63.75%65.96%67.34%67.13%70.5%64.38%
Gross Profit63.33M47.44M46.78M43.25M39.54M43.26M39.74M32.3M29.8M24.44M21.04M
Gross Margin %40.91%31.27%32.51%32.47%32.21%36.25%34.04%32.66%32.87%29.5%35.62%
Gross Profit Growth %60.18%9.65%17.72%33.88%32.69%77.01%--41.6%--
Operating Expenses42.76M29.63M27.67M27.33M25.07M25.01M23.92M24.89M20.74M18.63M14.46M
OpEx / Revenue %27.62%19.53%19.23%20.52%20.42%20.96%20.49%25.17%22.88%22.49%24.48%
Depreciation & Amortization0560K462K356K401K1.1M1.05M960K759K810K297K
Combined Ratio %86.71%88.26%86.72%88.05%88.21%84.71%86.45%92.51%90.01%92.99%88.86%
Operating Income20.57M17.81M19.11M15.92M14.47M18.25M15.82M7.41M9.06M5.81M6.58M
Operating Margin %13.29%11.74%13.28%11.95%11.79%15.29%13.55%7.49%9.99%7.01%11.14%
Operating Income Growth %42.16%-2.43%20.77%114.79%59.78%214.04%--37.63%--
EBITDA20.57M18.37M19.57M16.27M14.87M19.35M16.87M8.37M9.81M6.62M6.88M
EBITDA Margin %13.29%12.11%13.6%12.22%12.11%16.21%14.45%8.46%10.83%7.99%11.64%
Interest Expense01.24M262K261K247K248K252K224K1K00
Non-Operating Income0-1.24M-262K-261K-247K-248K-252K-224K000
Pretax Income20.57M17.81M19.11M15.92M14.47M18.25M15.82M7.41M9.06M5.81M6.58M
Pretax Margin %13.29%11.74%13.28%11.95%11.79%15.29%13.55%7.49%9.99%7.01%11.14%
Income Tax4.56M2.96M3.93M3.57M3.04M4.64M3.73M1.88M2.04M1.03M1.58M
Effective Tax Rate %22.17%16.64%20.57%22.46%21.04%25.44%23.57%25.33%22.57%17.67%24.01%
Net Income16.01M14.84M15.18M12.34M11.43M13.61M12.09M5.53M7.01M4.78M5M
Net Margin %10.34%9.78%10.55%9.27%9.31%11.4%10.36%5.59%7.74%5.77%8.46%
Net Income Growth %40.13%9.09%25.5%123.06%62.93%184.41%--40.24%--
EPS (Diluted)0.480.440.450.360.340.410.360.200.220.150.16
EPS Growth %41.18%7.32%25%80%54.55%173.33%--37.5%--
EPS (Basic)0.490.450.460.380.350.420.370.200.220.150.16
Diluted Shares Outstanding33.28M33.65M33.65M34.05M33.71M33.57M33.26M27.77M31.53M31.53M31.53M